Surgical Procedure, UnspecifiedNCT03854669
Experimental Pain Reporting Accuracy and Clinical Post-operative Pain
A study testing pain reporting accuracy in people with Surgical Procedure, Unspecified and Pain, Postoperative, run by Carmel Medical Center at 1 site in Israel.
Trial summary
Pain is a subjective experience that differs in intensity from one person to another. Appropriate medical care relies on an accurate assessment of the patients' condition. However, when it comes to subjective assessment, accurate assessment is a challenge. Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Surgical Procedure, Unspecified, Pain, Postoperative, Ear, Nose, and Throat (ENT) Disease
- What is being tested?
- pain reporting accuracy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteIsrael
- Study dates
- 1 Sep 2019to Apr 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age >18
- Candidates to Head \& Neck elective surgery
Who cannot join
- Presence of diagnosed psychiatric disorders, cognitive and /or neurological deficits;
- Use of analgesic, anti-depressants or anti-anxiolytics medications on a regular basis (except for oral contraceptives);
- Pregnancy.
- Inability to give informed consent, communicate, and understand the purpose and instructions of this study.
Trial locations and contacts
1 site in 1 country.
Israel1 site, 1 recruiting
- Recruiting
Carmel Medical Center
Haifa, 3436212
Tal Honigman, MD, TalHo@clalit.org.il
Liat Honigman, PhD, lhonigman@staff.haifa.ac.il
About this study
Official title: Does Pain Reporting Accuracy Relates to the Intensity of Acute Post-operative Pain and Analgesic Drug Consumption?
Pain is a subjective experience that differs in intensity from one person to another. Appropriate medical care relies on an accurate assessment of the patients' condition. However, when it comes to subjective assessment, accurate assessment is a challenge.
The most common tools used to estimate pain intensity depend on patient pain reports on a numerical pain scale (NPS) or a similar scales. Although these tools are widely used, there is a tendency to ignore the fact that the reliability and accuracy of pain reports are strongly influenced not only by the measuring instrument, but also by the person who uses it. A method has recently been developed to assess the accuracy of pain reports, and in a series of studies it has been found that the more accurate a person is in pain reports in response to stimulation,the smaller his placebo effect is .The aim of the study is to investigate whether assessing the accuracy of a person's pain reports can predict who will experience intensified post-operative pain and post-operative analgesic medications intake.The study will include 40 patients undergoing elective head \& neck surgery. The study will be conducted prospectively and will include one pre-operative meeting to assess the accuracy of pain reports using the Focused Analgesia Selection Test (FAST). Patients will also complete pain-related psychological questionnaires during the session. In addition, post-operative pain measurements (NPS), and the use of pain relieving drugs (SOS) will be taken until release.
Read the detailed description
Objectives and hypotheses: The purpose of this study is to examine whether pain reporting accuracy (as examined in the FAST test) predicts the intensity of acute post-operative pain and the consumption of pain-relieving drugs. The investigators hypothesize that the more accurate a person is in his pain reports, the more likely he will be to correlate postoperative pain and Analgesic drugs consumption.
The study population: The sample will include 40 subjects (men and women) who are about to undergo elective head \& neck surgery in the Department of Otolaryngology.
Study design:
The institutional ethics committee of Carmel Medical Center approved the study protocol in accordance with the Helsinki Declaration, and written consent will be obtained from each subject before the beginning of the experiment. Participants will be enrolled into the study after meeting the inclusion criteria. The experiment will consist of one session, which will last about 45 minutes, during which the subject will undergo brief familiarization with the device, the stimulation and the scale in the study. Thereafter, all subjects will undergo the FAST procedure. Between the familiarization and the FAST, the subject will fill out pain-related personality questionnaires. From the moment of returning to the department after the surgery, the clinical follow-up will begin following pain reports and the consumption of pain-relieving drugs until the patient is released.
Psychophysical assessment: The contact-heat Q-sense system (Medoc, Ramat-Yishai, Israel) will be used to deliver the tonic heat stimulations applied by a 30 x 30 mm Peltier surface stimulator, which will be attached by Velcro straps to the volar surface of the forearm of the subject hand.
Familiarization: At the beginning of the experimental session, all subjects will undergo a short training in order to familiarize them with the device and with the sensations evoked by the painful stimulation, and to train them to report their perceived pain intensity using the numerical pain scale. The training will include exposure to three short contact-heat stimuli (44, 46.5, and 48°C), each lasting for 7 seconds from the time that the stimulation intensity reach the destination temperature. Subjects will be asked to report their pain on numerical pain scale (NPS) ranging from 0, denoting no pain, to 100, denoting the worst pain imaginable, induced by each stimulus.
Pain reporting accuracy assessment: Will be assessed by the FAST procedure. During the procedure, the thermode will be attached to the ventral surface of the subject's non-dominant arm and the temperature will be raised from a baseline of 32°C, peaks for 3 seconds at 1 of 7 designated temperatures (44°C, 45°C, 46°C, 47°C, 48°C, 49°C, and 50°C), and then decreased down to the baseline. Stimulus rate of rise and fall will be kept constant. Subjects will be asked to rate the peak pain intensity of each stimulus verbally using the NPS. Each temperature will be presented 7 times in a random block-ordered design (49 stimuli in total), with Inter-stimulus intervals of 20 seconds. The location of the thermode will be adjusted every 10 stimuli to minimize sensitization and/or habituation effects.
Evaluation of clinical variables: The clinical follow-up of patients begins from the moment the operation ends and continues until discharge (24-48 hours post-operation), and includes two measures:
- Pain reports (NPS) - pain assessment at the time of analgesic medication consumption and an hour after administration of the drug, in addition to regular monitoring of every 6 hours during hospitalization. The reports will be documented by the nursing staff.
- Follow-up after use of analgesic medications (according to the standard protocol + SOS medications including: Paracetamol IV, Optalgin PO, Oxycodone PO and Trimal IV).
Pain-related psychological questionnaires:
Pain sensitivity will be assessed by the Pain Sensitivity Questionnaire (PSQ). Dispositional optimism will be assessed by the Life Orientation Test-Revised (LOT-R).
Data analysis:
Data will be processed and analyzed using Excel , and SPSS® software version 23.
Descriptive statistics will be used to present demographic and baseline characteristics. Pain scores captured during the FAST procedure will be used to calculate 3 FAST outcomes as follows: 1) R2 will be calculated by using a power model regression. Disparity between the predicted function and actual scores could be a result of inaccuracy or unreliability. Close concordance between actual and predicted scores (higher R2) suggests greater accuracy and reliability. 2) Intraclass correlation coefficient (ICC) will be computed using a 2-way mixed model for the 7 presentations of each of the 7 intensity levels. An ICC score approaching 1.0 denotes a high degree of reliability or the agreement in responses to the same stimulus over several presentations. 3) The coefficient of variation (CoV) is the ratio of the standard deviation to the mean. The average CoV will be calculated as the mean of 7 CoVs, 1 at each stimulus level. Spearman's correlation between FAST outcome measures, NPS, analgesic consumption, PSQ and LOT-R will be calculated in order to assess relationships between pain reporting accuracy, clinical post-operative pain and pain-relates psychological measures. Exploring whether being identified as more painful patient in the acute post-operative phase (pro-nociceptive) could be predicted by pain reporting accuracy (as measures by FAST), and pain sensitivity (as assessed by PSQ) and optimism (as assessed by LOT-R) will be made by multivariate regression analyses.Statistical significance was defined as P≤0.05.
- Being tested
- pain reporting accuracy
- Keywords
- Acute post-operative pain, Clinical pain variability, Experimental pain variability, FAST, pain reporting accuracy
- Medical subject headings
- Pain, Postoperative, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pain reporting accuracyDevice
pain reporting accuracy will be assessed by the Focused Analgesia Selection Task (FAST) procedure. The FAST is based on recording a subject's pain reports in response to repeated administration of thermal noxious stimuli of various intensities, applied on the non-dominant arm with the Medoc® Thermal Sensory Analyzer II. The subjects will receive 1 of 7 designated temperatures (44°C, 45°C, 46°C, 47°C, 48°C, 49°C, and 50°C), each presented 7 times in a random block-ordered design (49 stimuli in total).
| Study group | Role | What they receive |
|---|---|---|
| Assessing pain reporting accuracy | Experimental | Subjects will undergo pre-operative evaluation of their pain reporting accuracy ability in order to assess its relation to post-operative acute pain and analgesic consumption Receives: Device: pain reporting accuracy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in acute post-operative pain throughout the hospitalization period
Subjects will be asked to report their pain on numerical pain scale (NPS) ranging from 0, denoting "no pain", to 10, denoting "the worst pain imaginable".
Measured: From post-surgery recovery until discharge at specific time points: pain report (NPS) at the time of analgesic medication consumption, an hour after administration of the drug, in addition to regular monitoring of every 6 hours during hospitalization.
Amount of analgesic drugs consumption I
Quantification of the amount of analgesic drugs consumption will be performed by counting the number of times an SOS drug has been given. The SOS medications (beyond analgesic protocol) include Optalgin PO / Acamol IV / Oxycodone PO/ tramal IV.
Measured: From post-surgery recovery until discharge (24-48 hours after surgery)
Secondary outcomes (2)
Amount of analgesic drugs consumption II
Quantification of the amount of analgesic drugs consumption will be performed by conversion of opiates dosage into morphine units, out of the SOS medications that were taken.
Measured: From post-surgery recovery until discharge (24-48 hours after surgery)
Amount of analgesic drugs consumption III
Quantification of the amount of analgesic drugs consumption will be performed by calculating the grams of NSAIDs consumption, out of the SOS medications that were taken.
Measured: From post-surgery recovery until discharge (24-48 hours after surgery)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Feb 2019
- Study start1 Sep 2019
- Primary completionApr 2020 (estimated)
- Study completionApr 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Surgical Procedure, UnspecifiedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Carmel Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- University of Haifa
- Responsible party
- Principal investigator, Tal Honigman, Carmel Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03854669
- Sponsor's protocol ID
- CMC-18-0082-CTIL
- Status last verified
- Jan 2020
- First submitted
- 13 Feb 2019
- Last updated
- 28 Jan 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Pain Reporting Accuracy Relates to the Intensity of Acute Post-operative Pain and Analgesic Drug Consumption?
- ClinicalTrials.gov ID
- NCT03854669
- Acronym / sponsor ID
- CMC-18-0082-CTIL
- Keywords
- Acute post-operative pain, Clinical pain variability, Experimental pain variability, FAST, pain reporting accuracy
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Carmel Medical CenterUniversity, hospital or other
- Collaborators
- University of Haifa
- Study start
- 1 Sep 2019 (actual)
- Primary completion
- Apr 2020 (estimated)
- Study completion
- Apr 2020 (estimated)
- First posted
- 26 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pain is a subjective experience that differs in intensity from one person to another. Appropriate medical care relies on an accurate assessment of the patients' condition. However, when it comes to subjective assessment, accurate assessment is a challenge.
The most common tools used to estimate pain intensity depend on patient pain reports on a numerical pain scale (NPS) or a similar scales. Although these tools are widely used, there is a tendency to ignore the fact that the reliability and accuracy of pain reports are strongly influenced not only by the measuring instrument, but also by the person who uses it. A method has recently been developed to assess the accuracy of pain reports, and in a series of studies it has been found that the more accurate a person is in pain reports in response to stimulation,the smaller his placebo effect is .The aim of the study is to investigate whether assessing the accuracy of a person's pain reports can predict who will experience intensified post-operative pain and post-operative analgesic medications intake.The study will include 40 patients undergoing elective head \& neck surgery. The study will be conducted prospectively and will include one pre-operative meeting to assess the accuracy of pain reports using the Focused Analgesia Selection Test (FAST). Patients will also complete pain-related psychological questionnaires during the session. In addition, post-operative pain measurements (NPS), and the use of pain relieving drugs (SOS) will be taken until release.
Detailed description
Objectives and hypotheses: The purpose of this study is to examine whether pain reporting accuracy (as examined in the FAST test) predicts the intensity of acute post-operative pain and the consumption of pain-relieving drugs. The investigators hypothesize that the more accurate a person is in his pain reports, the more likely he will be to correlate postoperative pain and Analgesic drugs consumption.
The study population: The sample will include 40 subjects (men and women) who are about to undergo elective head \& neck surgery in the Department of Otolaryngology.
Study design:
The institutional ethics committee of Carmel Medical Center approved the study protocol in accordance with the Helsinki Declaration, and written consent will be obtained from each subject before the beginning of the experiment. Participants will be enrolled into the study after meeting the inclusion criteria. The experiment will consist of one session, which will last about 45 minutes, during which the subject will undergo brief familiarization with the device, the stimulation and the scale in the study. Thereafter, all subjects will undergo the FAST procedure. Between the familiarization and the FAST, the subject will fill out pain-related personality questionnaires. From the moment of returning to the department after the surgery, the clinical follow-up will begin following pain reports and the consumption of pain-relieving drugs until the patient is released.
Psychophysical assessment: The contact-heat Q-sense system (Medoc, Ramat-Yishai, Israel) will be used to deliver the tonic heat stimulations applied by a 30 x 30 mm Peltier surface stimulator, which will be attached by Velcro straps to the volar surface of the forearm of the subject hand.
Familiarization: At the beginning of the experimental session, all subjects will undergo a short training in order to familiarize them with the device and with the sensations evoked by the painful stimulation, and to train them to report their perceived pain intensity using the numerical pain scale. The training will include exposure to three short contact-heat stimuli (44, 46.5, and 48°C), each lasting for 7 seconds from the time that the stimulation intensity reach the destination temperature. Subjects will be asked to report their pain on numerical pain scale (NPS) ranging from 0, denoting no pain, to 100, denoting the worst pain imaginable, induced by each stimulus.
Pain reporting accuracy assessment: Will be assessed by the FAST procedure. During the procedure, the thermode will be attached to the ventral surface of the subject's non-dominant arm and the temperature will be raised from a baseline of 32°C, peaks for 3 seconds at 1 of 7 designated temperatures (44°C, 45°C, 46°C, 47°C, 48°C, 49°C, and 50°C), and then decreased down to the baseline. Stimulus rate of rise and fall will be kept constant. Subjects will be asked to rate the peak pain intensity of each stimulus verbally using the NPS. Each temperature will be presented 7 times in a random block-ordered design (49 stimuli in total), with Inter-stimulus intervals of 20 seconds. The location of the thermode will be adjusted every 10 stimuli to minimize sensitization and/or habituation effects.
Evaluation of clinical variables: The clinical follow-up of patients begins from the moment the operation ends and continues until discharge (24-48 hours post-operation), and includes two measures:
- Pain reports (NPS) - pain assessment at the time of analgesic medication consumption and an hour after administration of the drug, in addition to regular monitoring of every 6 hours during hospitalization. The reports will be documented by the nursing staff.
- Follow-up after use of analgesic medications (according to the standard protocol + SOS medications including: Paracetamol IV, Optalgin PO, Oxycodone PO and Trimal IV).
Pain-related psychological questionnaires:
Pain sensitivity will be assessed by the Pain Sensitivity Questionnaire (PSQ). Dispositional optimism will be assessed by the Life Orientation Test-Revised (LOT-R).
Data analysis:
Data will be processed and analyzed using Excel , and SPSS® software version 23.
Descriptive statistics will be used to present demographic and baseline characteristics. Pain scores captured during the FAST procedure will be used to calculate 3 FAST outcomes as follows: 1) R2 will be calculated by using a power model regression. Disparity between the predicted function and actual scores could be a result of inaccuracy or unreliability. Close concordance between actual and predicted scores (higher R2) suggests greater accuracy and reliability. 2) Intraclass correlation coefficient (ICC) will be computed using a 2-way mixed model for the 7 presentations of each of the 7 intensity levels. An ICC score approaching 1.0 denotes a high degree of reliability or the agreement in responses to the same stimulus over several presentations. 3) The coefficient of variation (CoV) is the ratio of the standard deviation to the mean. The average CoV will be calculated as the mean of 7 CoVs, 1 at each stimulus level. Spearman's correlation between FAST outcome measures, NPS, analgesic consumption, PSQ and LOT-R will be calculated in order to assess relationships between pain reporting accuracy, clinical post-operative pain and pain-relates psychological measures. Exploring whether being identified as more painful patient in the acute post-operative phase (pro-nociceptive) could be predicted by pain reporting accuracy (as measures by FAST), and pain sensitivity (as assessed by PSQ) and optimism (as assessed by LOT-R) will be made by multivariate regression analyses.Statistical significance was defined as P≤0.05.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Assessing pain reporting accuracy | Experimental | Device: pain reporting accuracySubjects will undergo pre-operative evaluation of their pain reporting accuracy ability in order to assess its relation to post-operative acute pain and analgesic consumption |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age >18
- Candidates to Head \& Neck elective surgery
Key exclusion criteria (4 listed)
- Presence of diagnosed psychiatric disorders, cognitive and /or neurological deficits;
- Use of analgesic, anti-depressants or anti-anxiolytics medications on a regular basis (except for oral contraceptives);
- Pregnancy.
- Inability to give informed consent, communicate, and understand the purpose and instructions of this study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pain reporting accuracypain reporting accuracy will be assessed by the Focused Analgesia Selection Task (FAST) procedure. The FAST is based on recording a subject's pain reports in response to repeated administration of thermal noxious stimuli of various intensities, applied on the non-dominant arm with the Medoc® Thermal Sensory Analyzer II. The subjects will receive 1 of 7 designated temperatures (44°C, 45°C, 46°C, 47°C, 48°C, 49°C, and 50°C), each presented 7 times in a random block-ordered design (49 stimuli in total). | Device | Assessing pain reporting accuracy |
Primary outcome
Change in acute post-operative pain throughout the hospitalization period
Time frame: From post-surgery recovery until discharge at specific time points: pain report (NPS) at the time of analgesic medication consumption, an hour after administration of the drug, in addition to regular monitoring of every 6 hours during hospitalization.
Subjects will be asked to report their pain on numerical pain scale (NPS) ranging from 0, denoting "no pain", to 10, denoting "the worst pain imaginable".
Amount of analgesic drugs consumption I
Time frame: From post-surgery recovery until discharge (24-48 hours after surgery)
Quantification of the amount of analgesic drugs consumption will be performed by counting the number of times an SOS drug has been given. The SOS medications (beyond analgesic protocol) include Optalgin PO / Acamol IV / Oxycodone PO/ tramal IV.
2 secondary outcomes
Amount of analgesic drugs consumption II
Time frame: From post-surgery recovery until discharge (24-48 hours after surgery)
Amount of analgesic drugs consumption III
Time frame: From post-surgery recovery until discharge (24-48 hours after surgery)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2020.
Related trials for Surgical Procedure, Unspecified
Recruiting
Improving Surgical Communication for Patients in Wisconsin
Surgeons, Surgical Procedure, Unspecified
Active, not recruitingObservational study
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
Surgical Procedure, Unspecified, Intensive Care Units (ICUs)
RecruitingPhase 4
A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements
Fracture Arm, Fracture Closed of Lower End of Forearm, Unspecified
Not yet recruitingPhase 4
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Recruiting
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
Critical Illness, Surgical Procedure, Unspecified
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing pain reporting accuracy in people with Surgical Procedure, Unspecified and Pain, Postoperative, run by Carmel Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Tal Honigman, MD (972-(0)4-8250433, TalHo@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in acute post-operative pain throughout the hospitalization period (time frame: From post-surgery recovery until discharge at specific time points: pain report (NPS) at the time of analgesic medication consumption, an hour after administration of the drug, in addition to regular monitoring of every 6 hours during hospitalization.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2020.